secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001140361-24-037388
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres files prior financials for proxy on VOWST asset sale; auditor flags going concern
--------------------------------------------------------------------------------

- Furnishes 2022-2023 audited financial statements for incorporation in proxy statement related to sale of VOWST microbiome assets.
- Auditor notes substantial doubt about ability to continue as going concern due to recurring losses and negative cash flows.
- Financial statements consistent with prior Form 10-K filed March 5, 2024; no updates for subsequent events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000114036124037388/0001140361-24-037388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000114036124037388/ny20030749x9_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-037388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer